Vet Microbiol 2000, 71:201–210.PubMedCrossRef 13. Tola S, Manunta D, Rocca S, Rocchigiani AM, Idini G, Angioi PP, Leori G: Experimental vaccination against Mycoplasma agalactiae using Nutlin-3a supplier different inactivated vaccines. Vaccine 1999, 10:2764–2768.CrossRef 14. Chopra-Dewasthaly R, Citti C, Glew MD, Zimmermann M, Rosengarten R, Jechlinger W: Phase-locked mutants of Mycoplasma agalactiae : defining the molecular switch of high-frequency
Vpma antigenic variation. Mol Microbiol 2008, 67:1196–1210.PubMedCrossRef 15. McAuliffe L, Kokotovich B, Ayling RD, Nicholas RA: Molecular epidemiological analysis of Mycoplasma bovis isolates from the United Kingdom shows two genetically distinct clusters. J Clin Microbiol 2004, 42:4556–4565.PubMedCrossRef 16. Citti C, Watson-McKown R, Droesse M, Wise KS: Gene families encoding phase- and size-variable surface lipoproteins of Mycoplasma hyorhinis . J Bacteriol 2000, 182:1356–1363.PubMedCrossRef 17. Glew MD, Papazisi L, Poumarat F, Bergonier D, Rosengarten R, Citti C: Characterization of a multigene family undergoing
high-frequency DNA rearrangements and coding for abundant variable surface proteins in Mycoplasma agalactiae . Infect Immun 2000, 68:4539–4548.PubMedCrossRef 18. Fleury B, Bergonier D, Berthelot X, Peterhans E, Frey J, Vilei EM: Characterization of P40, a cytadhesin of Mycoplasma agalactiae . Infect Immun 2002, 70:5612–5621.PubMedCrossRef 19. Fleury B, Bergonier D, Berthelot X, Schlatter Y, Frey J, Vilei EM: Characterization and analysis of a stable serotype-associated membrane PDGFR inhibitor protein (P30) of Mycoplasma agalactiae . J Clin Microbiol 2001, 39:2814–2822.PubMedCrossRef 20. Rosati S, Pozzi S, Robino P, Montinaro B, Conti A, Fadda M, Pittau M: P48 major surface antigen of Mycoplasma agalactiae is homologous to a malp product of Mycoplasma fermentans Cytoskeletal Signaling inhibitor and belongs to a selected family of bacterial lipoproteins. Infect Immun 1999, 67:6213–6216.PubMed
21. Tola S, Crobeddu S, Chessa G, Uzzau S, Idini G, Ibba B, Rocca S: Sequence, cloning, expression and characterisation of the 81-kDa surface membrane protein (P80) of Mycoplasma agalactiae . FEMS Microbiol Lett 2001, 202:45–50.PubMedCrossRef 22. Jores J, Meens J, Buettner FF, Linz B, Naessens J, Gerlach GF: Analysis of the immunoproteome of Mycoplasma mycoides subsp. mycoides small colony type reveals immunogenic homologues to other known virulence traits in related Mycoplasma species. Vet Immunol Immunopathol 2009, 131:238–245.PubMedCrossRef 23. Minion FC: Mycoplasma gene expression in Escherichia coli . Methods Mol Biol 1998, 104:259–265.PubMed 24. Sirand-Pugnet P, Lartigue C, Marenda M, Jacob D, Barré A, Barbe V, Schenowitz C, Mangenot S, BAY 73-4506 clinical trial Couloux A, Segurens B, de Daruvar A, Blanchard A, Citti C: Being pathogenic, plastic, and sexual while living with a nearly minimal bacterial genome. PLoS Genet 2007, 3:e75.PubMedCrossRef 25. Görg A, Weiss W, Dunn MJ: Current two-dimensional electrophoresis technology for proteomics.